China Pharma Holdings Inc
CPHI0.694USD
+0.034+5.37%
종가 02/06, 16:00（ET）시세는 15분 지연됩니다
3.48M시가총액
손실P/E TTM
자세한 내용은 China Pharma Holdings Inc 회사
China Pharma Holdings Inc is a company principally engaged in the development, manufacture and marketing of pharmaceutical products. The Company's products are for human use in connection, and with a variety of high-incidence and high-mortality diseases and medical conditions prevalent. The Company manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. In addition, the Company is also engaged in the production of comprehensive healthcare products and protective products.
China Pharma Holdings Inc 정보
종목 코드 CPHI
회사 이름China Pharma Holdings Inc
상장일Feb 15, 2000
CEOLi (Zhilin)
직원 수224
유형Ordinary Share
회계 연도 종료Feb 15
주소2nd Floor, No. 17, Jinpan Road
도시HAIKOU
증권 거래소NASDAQ OMX – NASDAQ Basic Amex
국가China
우편 번호570216
전화8689866811730
웹사이트http://www.chinapharmaholdings.com
종목 코드 CPHI
상장일Feb 15, 2000
CEOLi (Zhilin)
China Pharma Holdings Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Ms. Zhilin Li
Ms. Zhilin Li
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer
302.76K
+1.00%
Ms. Heung Mei Tsui
Ms. Heung Mei Tsui
Director
Director
18.63K
+1.00%
Mr. Gene Michael Bennett
Mr. Gene Michael Bennett
Independent Director
Independent Director
--
--
Yingwen Zhang
Yingwen Zhang
Independent Director
Independent Director
--
--
Mr. Baowen Dong
Mr. Baowen Dong
Independent Director
Independent Director
--
--
이름
이름/직위
직위
주식 보유
변동
Ms. Zhilin Li
Ms. Zhilin Li
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer
302.76K
+1.00%
Ms. Heung Mei Tsui
Ms. Heung Mei Tsui
Director
Director
18.63K
+1.00%
Mr. Gene Michael Bennett
Mr. Gene Michael Bennett
Independent Director
Independent Director
--
--
Yingwen Zhang
Yingwen Zhang
Independent Director
Independent Director
--
--
Mr. Baowen Dong
Mr. Baowen Dong
Independent Director
Independent Director
--
--
수익 분석
통화: USD마지막 업데이트: Tue, Jan 6
통화: USD마지막 업데이트: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
사업별USD
이름
수익
비율
Domestic Pharmaceuticals
756.22K
0.00%
기업이 아직 관련 데이터를 공개하지 않았습니다.
사업별
지역별
사업별USD
이름
수익
비율
Domestic Pharmaceuticals
756.22K
0.00%
주식 보유 통계
마지막 업데이트: Fri, Jan 2
마지막 업데이트: Fri, Jan 2
주주
주주 유형
주주
주주
비율
Yang (Yan)
8.96%
Zhan (Wenlong)
8.16%
Jianying (Cai)
7.96%
Lai (Kui)
7.96%
Lihua (Li)
7.96%
기타
58.98%
주주
주주
비율
Yang (Yan)
8.96%
Zhan (Wenlong)
8.16%
Jianying (Cai)
7.96%
Lai (Kui)
7.96%
Lihua (Li)
7.96%
기타
58.98%
주주 유형
주주
비율
Individual Investor
53.39%
Hedge Fund
0.82%
Investment Advisor
0.01%
기타
45.78%
기관 주식 보유
마지막 업데이트: Mon, Dec 8
마지막 업데이트: Mon, Dec 8
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
15
76.44K
2.51%
--
2025Q3
15
76.44K
3.87%
-42.24K
2025Q2
15
118.68K
1.40%
+84.90K
2025Q1
14
33.79K
0.88%
+5.19K
2024Q4
14
17.38K
1.34%
+13.31K
2024Q3
13
4.07K
1.47%
-1.93K
2024Q2
13
6.00K
1.31%
-5.59K
2024Q1
11
11.59K
0.89%
-1.57K
2023Q4
12
12.24K
0.98%
+6.13K
2023Q3
12
6.11K
1.50%
+3.00K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Yang (Yan)
450.00K
8.96%
+450.00K
--
Nov 03, 2025
Zhan (Wenlong)
410.00K
8.16%
+410.00K
--
Nov 03, 2025
Jianying (Cai)
400.00K
7.96%
+300.00K
+300.00%
Nov 03, 2025
Lai (Kui)
400.00K
7.96%
+300.00K
+300.00%
Nov 03, 2025
Lihua (Li)
400.00K
7.96%
+300.00K
+300.00%
Nov 03, 2025
Li (Zhilin)
302.76K
6.03%
+1.00
+0.00%
Nov 03, 2025
Liu (Tao Chengdu)
300.00K
5.97%
--
--
Nov 03, 2025
Citadel Advisors LLC
30.43K
0.61%
+7.36K
+31.89%
Sep 30, 2025
Tsui (Heung Mei)
18.63K
0.37%
+1.00
+0.01%
Nov 03, 2025
Renaissance Technologies LLC
10.62K
0.21%
+10.62K
--
Sep 30, 2025
더 보기
관련 ETF
이름
비율
데이터 없음
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
Apr 04, 2025
Merger
10→1
Dec 20, 2023
Merger
5→1
Dec 20, 2023
Merger
5→1
Dec 20, 2023
Merger
5→1
Dec 20, 2023
Merger
5→1
Feb 24, 2023
Merger
10→1
날짜
배당락일
유형
비율
Apr 04, 2025
Merger
10→1
Dec 20, 2023
Merger
5→1
Dec 20, 2023
Merger
5→1
Dec 20, 2023
Merger
5→1
Dec 20, 2023
Merger
5→1
Feb 24, 2023
Merger
10→1
Feb 24, 2023
Merger
10→1
Feb 24, 2023
Merger
10→1
Feb 24, 2023
Merger
10→1
